| UniProt ID | CDC27_HUMAN | |
|---|---|---|
| UniProt AC | P30260 | |
| Protein Name | Cell division cycle protein 27 homolog | |
| Gene Name | CDC27 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 824 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains.. | |
| Protein Sequence | MTVLQEPVQAAIWQALNHYAYRDAVFLAERLYAEVHSEEALFLLATCYYRSGKAYKAYRLLKGHSCTTPQCKYLLAKCCVDLSKLAEGEQILSGGVFNKQKSHDDIVTEFGDSACFTLSLLGHVYCKTDRLAKGSECYQKSLSLNPFLWSPFESLCEIGEKPDPDQTFKFTSLQNFSNCLPNSCTTQVPNHSLSHRQPETVLTETPQDTIELNRLNLESSNSKYSLNTDSSVSYIDSAVISPDTVPLGTGTSILSKQVQNKPKTGRSLLGGPAALSPLTPSFGILPLETPSPGDGSYLQNYTNTPPVIDVPSTGAPSKKSVARIGQTGTKSVFSQSGNSREVTPILAQTQSSGPQTSTTPQVLSPTITSPPNALPRRSSRLFTSDSSTTKENSKKLKMKFPPKIPNRKTKSKTNKGGITQPNINDSLEITKLDSSIISEGKISTITPQIQAFNLQKAAAEGLMSLLREMGKGYLALCSYNCKEAINILSHLPSHHYNTGWVLCQIGRAYFELSEYMQAERIFSEVRRIENYRVEGMEIYSTTLWHLQKDVALSVLSKDLTDMDKNSPEAWCAAGNCFSLQREHDIAIKFFQRAIQVDPNYAYAYTLLGHEFVLTEELDKALACFRNAIRVNPRHYNAWYGLGMIYYKQEKFSLAEMHFQKALDINPQSSVLLCHIGVVQHALKKSEKALDTLNKAIVIDPKNPLCKFHRASVLFANEKYKSALQELEELKQIVPKESLVYFLIGKVYKKLGQTHLALMNFSWAMDLDPKGANNQIKEAIDKRYLPDDEEPITQEEQIMGTDESQESSMTDADDTQLHAAESDEF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 62 | Ubiquitination | YKAYRLLKGHSCTTP HHHHHHHCCCCCCCH | 60.20 | - | |
| 68 | Phosphorylation | LKGHSCTTPQCKYLL HCCCCCCCHHHHHHH | 18.71 | - | |
| 72 | Ubiquitination | SCTTPQCKYLLAKCC CCCCHHHHHHHHHHH | 33.41 | - | |
| 77 | Acetylation | QCKYLLAKCCVDLSK HHHHHHHHHHCCHHH | 28.30 | 7226429 | |
| 77 | Ubiquitination | QCKYLLAKCCVDLSK HHHHHHHHHHCCHHH | 28.30 | - | |
| 84 | Ubiquitination | KCCVDLSKLAEGEQI HHHCCHHHHHCCCCH | 60.04 | - | |
| 99 | Acetylation | LSGGVFNKQKSHDDI HCCCCCCCCCCCCHH | 47.87 | 25953088 | |
| 99 | Ubiquitination | LSGGVFNKQKSHDDI HCCCCCCCCCCCCHH | 47.87 | 21890473 | |
| 133 | Ubiquitination | CKTDRLAKGSECYQK ECCCHHCCCCHHHHH | 68.51 | - | |
| 154 | Phosphorylation | FLWSPFESLCEIGEK HHCCCHHHHHHCCCC | 38.40 | 21209074 | |
| 177 | Phosphorylation | FTSLQNFSNCLPNSC EEECCCHHCCCCCCC | 33.90 | 21712546 | |
| 183 | Phosphorylation | FSNCLPNSCTTQVPN HHCCCCCCCCCCCCC | 15.76 | 29214152 | |
| 185 | Phosphorylation | NCLPNSCTTQVPNHS CCCCCCCCCCCCCCC | 21.78 | 21712546 | |
| 186 | Phosphorylation | CLPNSCTTQVPNHSL CCCCCCCCCCCCCCC | 31.71 | 21712546 | |
| 192 | Phosphorylation | TTQVPNHSLSHRQPE CCCCCCCCCCCCCCC | 37.90 | 25159151 | |
| 194 | Phosphorylation | QVPNHSLSHRQPETV CCCCCCCCCCCCCCE | 21.46 | 21712546 | |
| 200 | Phosphorylation | LSHRQPETVLTETPQ CCCCCCCCEEECCCC | 27.74 | 21815630 | |
| 203 | Phosphorylation | RQPETVLTETPQDTI CCCCCEEECCCCCCE | 33.21 | 30266825 | |
| 205 | Phosphorylation | PETVLTETPQDTIEL CCCEEECCCCCCEEE | 22.48 | 30266825 | |
| 209 | Phosphorylation | LTETPQDTIELNRLN EECCCCCCEEECCCC | 15.88 | 30266825 | |
| 219 | Phosphorylation | LNRLNLESSNSKYSL ECCCCCCCCCCCEEC | 37.68 | 23663014 | |
| 220 | Phosphorylation | NRLNLESSNSKYSLN CCCCCCCCCCCEECC | 35.43 | 30266825 | |
| 222 | Phosphorylation | LNLESSNSKYSLNTD CCCCCCCCCEECCCC | 34.61 | 23663014 | |
| 224 | Phosphorylation | LESSNSKYSLNTDSS CCCCCCCEECCCCCC | 20.43 | 29978859 | |
| 225 | Phosphorylation | ESSNSKYSLNTDSSV CCCCCCEECCCCCCC | 20.91 | 29978859 | |
| 228 | Phosphorylation | NSKYSLNTDSSVSYI CCCEECCCCCCCEEE | 42.42 | 29978859 | |
| 230 | Phosphorylation | KYSLNTDSSVSYIDS CEECCCCCCCEEEEE | 30.51 | 29978859 | |
| 231 | Phosphorylation | YSLNTDSSVSYIDSA EECCCCCCCEEEEEE | 20.21 | 29978859 | |
| 233 | Phosphorylation | LNTDSSVSYIDSAVI CCCCCCCEEEEEEEE | 20.51 | 28348404 | |
| 234 | Phosphorylation | NTDSSVSYIDSAVIS CCCCCCEEEEEEEEC | 13.44 | 28348404 | |
| 237 | Phosphorylation | SSVSYIDSAVISPDT CCCEEEEEEEECCCC | 18.19 | 28348404 | |
| 241 | Phosphorylation | YIDSAVISPDTVPLG EEEEEEECCCCCCCC | 15.32 | 26074081 | |
| 244 | Phosphorylation | SAVISPDTVPLGTGT EEEECCCCCCCCCCH | 27.66 | 26074081 | |
| 252 | Phosphorylation | VPLGTGTSILSKQVQ CCCCCCHHHHHHHHH | 23.91 | 24719451 | |
| 264 | Phosphorylation | QVQNKPKTGRSLLGG HHHCCCCCCCCCCCC | 46.48 | 22817900 | |
| 276 | Phosphorylation | LGGPAALSPLTPSFG CCCCCCCCCCCCCCC | 17.09 | 27251275 | |
| 279 | Phosphorylation | PAALSPLTPSFGILP CCCCCCCCCCCCEEE | 21.92 | 27251275 | |
| 289 | Phosphorylation | FGILPLETPSPGDGS CCEEECCCCCCCCCC | 36.43 | 22817900 | |
| 291 | Phosphorylation | ILPLETPSPGDGSYL EEECCCCCCCCCCCC | 49.27 | 22817900 | |
| 296 | Phosphorylation | TPSPGDGSYLQNYTN CCCCCCCCCCCCCCC | 27.66 | 22817900 | |
| 297 | Phosphorylation | PSPGDGSYLQNYTNT CCCCCCCCCCCCCCC | 20.17 | 27251275 | |
| 301 | Phosphorylation | DGSYLQNYTNTPPVI CCCCCCCCCCCCCEE | 6.60 | 27251275 | |
| 302 | Phosphorylation | GSYLQNYTNTPPVID CCCCCCCCCCCCEEC | 39.92 | 27251275 | |
| 304 | Phosphorylation | YLQNYTNTPPVIDVP CCCCCCCCCCEECCC | 22.59 | 22067460 | |
| 312 | Phosphorylation | PPVIDVPSTGAPSKK CCEECCCCCCCCCHH | 39.04 | 22817900 | |
| 313 | Phosphorylation | PVIDVPSTGAPSKKS CEECCCCCCCCCHHH | 31.15 | 22817900 | |
| 313 (in isoform 2) | Phosphorylation | - | 31.15 | - | |
| 319 | Ubiquitination | STGAPSKKSVARIGQ CCCCCCHHHHEECCC | 55.27 | - | |
| 320 | Phosphorylation | TGAPSKKSVARIGQT CCCCCHHHHEECCCC | 25.42 | 22067460 | |
| 320 (in isoform 2) | Phosphorylation | - | 25.42 | - | |
| 326 | Phosphorylation | KSVARIGQTGTKSVF HHHEECCCCCCCHHH | 34.09 | - | |
| 326 (in isoform 2) | Phosphorylation | - | 34.09 | - | |
| 327 | Phosphorylation | SVARIGQTGTKSVFS HHEECCCCCCCHHHC | 41.42 | - | |
| 329 | Phosphorylation | ARIGQTGTKSVFSQS EECCCCCCCHHHCCC | 24.43 | 22817900 | |
| 330 | Acetylation | RIGQTGTKSVFSQSG ECCCCCCCHHHCCCC | 46.06 | 26051181 | |
| 330 | Ubiquitination | RIGQTGTKSVFSQSG ECCCCCCCHHHCCCC | 46.06 | 21906983 | |
| 333 | Phosphorylation | QTGTKSVFSQSGNSR CCCCCHHHCCCCCCC | 7.69 | - | |
| 334 | O-linked_Glycosylation | TGTKSVFSQSGNSRE CCCCHHHCCCCCCCE | 22.68 | 23301498 | |
| 334 | Phosphorylation | TGTKSVFSQSGNSRE CCCCHHHCCCCCCCE | 22.68 | 26055452 | |
| 335 | Phosphorylation | GTKSVFSQSGNSREV CCCHHHCCCCCCCEE | 43.84 | - | |
| 336 | Phosphorylation | TKSVFSQSGNSREVT CCHHHCCCCCCCEEC | 38.45 | 25159151 | |
| 339 | Phosphorylation | VFSQSGNSREVTPIL HHCCCCCCCEECCEE | 33.09 | 25159151 | |
| 342 | Phosphorylation | QSGNSREVTPILAQT CCCCCCEECCEEEEC | 8.19 | 27251275 | |
| 343 | Phosphorylation | SGNSREVTPILAQTQ CCCCCEECCEEEECC | 10.39 | 14657031 | |
| 349 | Phosphorylation | VTPILAQTQSSGPQT ECCEEEECCCCCCCC | 25.47 | 29632367 | |
| 351 | Phosphorylation | PILAQTQSSGPQTST CEEEECCCCCCCCCC | 40.42 | 29632367 | |
| 352 | Phosphorylation | ILAQTQSSGPQTSTT EEEECCCCCCCCCCC | 44.68 | 29632367 | |
| 356 | Phosphorylation | TQSSGPQTSTTPQVL CCCCCCCCCCCCCCC | 31.04 | 29632367 | |
| 357 | Phosphorylation | QSSGPQTSTTPQVLS CCCCCCCCCCCCCCC | 25.65 | 29632367 | |
| 358 | Phosphorylation | SSGPQTSTTPQVLSP CCCCCCCCCCCCCCC | 45.97 | 25022875 | |
| 359 | Phosphorylation | SGPQTSTTPQVLSPT CCCCCCCCCCCCCCC | 16.10 | 25022875 | |
| 364 | Phosphorylation | STTPQVLSPTITSPP CCCCCCCCCCCCCCC | 22.57 | 25159151 | |
| 366 | Phosphorylation | TPQVLSPTITSPPNA CCCCCCCCCCCCCCC | 33.25 | 14657031 | |
| 368 | Phosphorylation | QVLSPTITSPPNALP CCCCCCCCCCCCCCC | 37.34 | 30175587 | |
| 369 | Phosphorylation | VLSPTITSPPNALPR CCCCCCCCCCCCCCC | 34.21 | 26055452 | |
| 370 | Phosphorylation | LSPTITSPPNALPRR CCCCCCCCCCCCCCC | 19.95 | 24719451 | |
| 378 | Phosphorylation | PNALPRRSSRLFTSD CCCCCCCCCCCCCCC | 22.53 | 25159151 | |
| 379 | Phosphorylation | NALPRRSSRLFTSDS CCCCCCCCCCCCCCC | 31.06 | 27273156 | |
| 383 | Phosphorylation | RRSSRLFTSDSSTTK CCCCCCCCCCCCCCH | 35.89 | 25159151 | |
| 384 | Phosphorylation | RSSRLFTSDSSTTKE CCCCCCCCCCCCCHH | 28.32 | 25159151 | |
| 386 | Phosphorylation | SRLFTSDSSTTKENS CCCCCCCCCCCHHHH | 29.38 | 25159151 | |
| 387 | Phosphorylation | RLFTSDSSTTKENSK CCCCCCCCCCHHHHH | 45.12 | 25159151 | |
| 388 | Phosphorylation | LFTSDSSTTKENSKK CCCCCCCCCHHHHHH | 45.93 | 25159151 | |
| 389 | Phosphorylation | FTSDSSTTKENSKKL CCCCCCCCHHHHHHC | 38.01 | 25159151 | |
| 390 | Ubiquitination | TSDSSTTKENSKKLK CCCCCCCHHHHHHCC | 55.79 | - | |
| 393 | Phosphorylation | SSTTKENSKKLKMKF CCCCHHHHHHCCCCC | 32.05 | 26055452 | |
| 415 | Ubiquitination | KTKSKTNKGGITQPN CCCCCCCCCCCCCCC | 64.84 | 21906983 | |
| 419 | Phosphorylation | KTNKGGITQPNINDS CCCCCCCCCCCCCCC | 41.05 | 22210691 | |
| 426 | Phosphorylation | TQPNINDSLEITKLD CCCCCCCCEEEEECC | 24.34 | 30266825 | |
| 430 | Phosphorylation | INDSLEITKLDSSII CCCCEEEEECCHHHH | 19.04 | 30266825 | |
| 431 | Ubiquitination | NDSLEITKLDSSIIS CCCEEEEECCHHHHC | 56.83 | 21906983 | |
| 432 | Phosphorylation | DSLEITKLDSSIISE CCEEEEECCHHHHCC | 6.05 | 27251275 | |
| 434 | Phosphorylation | LEITKLDSSIISEGK EEEEECCHHHHCCCC | 33.60 | 30266825 | |
| 435 | Phosphorylation | EITKLDSSIISEGKI EEEECCHHHHCCCCC | 24.49 | 30266825 | |
| 438 | Phosphorylation | KLDSSIISEGKISTI ECCHHHHCCCCCCCC | 38.33 | 30266825 | |
| 441 | Ubiquitination | SSIISEGKISTITPQ HHHHCCCCCCCCCHH | 29.45 | 21890473 | |
| 443 | Phosphorylation | IISEGKISTITPQIQ HHCCCCCCCCCHHHH | 19.76 | 21815630 | |
| 444 | Phosphorylation | ISEGKISTITPQIQA HCCCCCCCCCHHHHH | 32.13 | 25159151 | |
| 446 | Phosphorylation | EGKISTITPQIQAFN CCCCCCCCHHHHHHH | 14.83 | 25159151 | |
| 452 | Phosphorylation | ITPQIQAFNLQKAAA CCHHHHHHHHHHHHH | 5.55 | 24719451 | |
| 523 | Phosphorylation | MQAERIFSEVRRIEN HHHHHHHHHHHCHHC | 32.58 | 24719451 | |
| 553 | Phosphorylation | LQKDVALSVLSKDLT HHHHHHHHHHCCCCC | 15.98 | 22817900 | |
| 557 | Ubiquitination | VALSVLSKDLTDMDK HHHHHHCCCCCCCCC | 53.23 | 21906983 | |
| 564 | Ubiquitination | KDLTDMDKNSPEAWC CCCCCCCCCCHHHHH | 53.33 | - | |
| 578 | Phosphorylation | CAAGNCFSLQREHDI HHHHCCHHCCCHHHH | 26.28 | - | |
| 588 | Ubiquitination | REHDIAIKFFQRAIQ CHHHHHHHHHHHHHC | 30.98 | 21890473 | |
| 685 | O-linked_Glycosylation | VQHALKKSEKALDTL HHHHHHHCHHHHHHC | 42.62 | 23301498 | |
| 687 | Ubiquitination | HALKKSEKALDTLNK HHHHHCHHHHHHCCC | 62.43 | - | |
| 691 | O-linked_Glycosylation | KSEKALDTLNKAIVI HCHHHHHHCCCCEEE | 32.83 | 23301498 | |
| 691 | Phosphorylation | KSEKALDTLNKAIVI HCHHHHHHCCCCEEE | 32.83 | 22817900 | |
| 694 | Ubiquitination | KALDTLNKAIVIDPK HHHHHCCCCEEECCC | 42.47 | 21890473 | |
| 701 | Acetylation | KAIVIDPKNPLCKFH CCEEECCCCCCCHHH | 68.40 | 26051181 | |
| 701 | Ubiquitination | KAIVIDPKNPLCKFH CCEEECCCCCCCHHH | 68.40 | - | |
| 706 | Ubiquitination | DPKNPLCKFHRASVL CCCCCCCHHHHHHHH | 52.46 | - | |
| 718 | Ubiquitination | SVLFANEKYKSALQE HHHHCCHHHHHHHHH | 58.76 | 21906983 | |
| 720 | Ubiquitination | LFANEKYKSALQELE HHCCHHHHHHHHHHH | 40.08 | 21906983 | |
| 721 | Phosphorylation | FANEKYKSALQELEE HCCHHHHHHHHHHHH | 30.99 | 28060719 | |
| 730 | Ubiquitination | LQELEELKQIVPKES HHHHHHHHCCCCHHH | 41.06 | 21906983 | |
| 735 | Ubiquitination | ELKQIVPKESLVYFL HHHCCCCHHHHHHHH | 49.38 | 21890473 | |
| 740 | Phosphorylation | VPKESLVYFLIGKVY CCHHHHHHHHHHHHH | 9.65 | 25147952 | |
| 753 | Phosphorylation | VYKKLGQTHLALMNF HHHHHCCCEEEEEEC | 19.63 | 28111955 | |
| 761 | Phosphorylation | HLALMNFSWAMDLDP EEEEEECHHHCCCCC | 14.66 | 28111955 | |
| 776 | Ubiquitination | KGANNQIKEAIDKRY CCCCHHHHHHHHHHC | 31.18 | - | |
| 809 | Phosphorylation | ESQESSMTDADDTQL CCHHCCCCCCCCCHH | 29.95 | 30576142 | |
| 821 | Phosphorylation | TQLHAAESDEF---- CHHHHHHCCCC---- | 37.40 | 22139841 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 154 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 205 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 205 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 209 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 209 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 222 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 289 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 312 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 329 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 343 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 364 | S | Phosphorylation | Kinase | CDK1 | P06493 | PhosphoELM |
| 379 | S | Phosphorylation | Kinase | PRKAA2 | P54646 | GPS |
| 426 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 426 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 430 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 430 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 434 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 434 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 435 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 435 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 446 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 446 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC27_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-426 AND THR-446, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-205; SER-339; SER-426;SER-435; SER-438 AND THR-446, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339; SER-435 ANDSER-438, AND MASS SPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435 AND SER-438, ANDMASS SPECTROMETRY. | |
| "Mitotic regulation of the human anaphase-promoting complex byphosphorylation."; Kraft C., Herzog F., Gieffers C., Mechtler K., Hagting A., Pines J.,Peters J.-M.; EMBO J. 22:6598-6609(2003). Cited for: PHOSPHORYLATION AT THR-205; THR-209; THR-244; SER-291; THR-313;SER-426; THR-430; SER-435 AND THR-446. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366, AND MASSSPECTROMETRY. | |